NORTHWEST BIOTHERAPEUTICS, INC.

Consensus Northwest Biotherapeutics, Inc.

Stocks

NWBO

US66737P6007

Biotechnology & Medical Research

Market Closed - OTC Markets 02:28:45 10/11/2026 am IST			5-day change	1st Jan Change
0.1669 ^USD	+0.25%		-5.12%	-27.04%

31/10	Northwest Biotherapeutics, Inc. Enters into Commercial Loan Agreement with Streeterville Capital, LLC for USD 5,505,000	CI
09/10	Northwest Biotherapeutics, Advent Bioservices And The UK National Health Service Blood And Transplant Announce Collaboration To Support DCVax®-L Production	CI

Evolution of the Average Target: Northwest Biotherapeutics, Inc.

Evolution of the Average Target - Northwest Biotherapeutics, Inc.

Evolution of the Target Price: Northwest Biotherapeutics, Inc.

Evolution of the Target Price - Northwest Biotherapeutics, Inc.

Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.

94c67.BFMy8CS6oXz7T3B_LmjTE5-4pvZYCGsaKu6tDN0-SV4.NTsFg0jekxmcAgQdViqZVKfpx5JtaS1sf5T0O7tpC2dJAUuJRcrHH4EgNQ~20f365ce9243e36f136b8c735df85338

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	NORTHWEST BIOTHERAPEUTICS, INC.			-	-	+500.67%
	WUXI APPTEC CO., LTD.					+37.65%
	ARGENX SE					+23.19%
	LONZA GROUP AG					+7.56%
	BEONE MEDICINES AG					+12.87%
	IQVIA HOLDINGS INC.					+14.74%
	REVOLUTION MEDICINES, INC.					+42.01%
	CELLTRION, INC.					+29.95%
	GENMAB A/S					+15.03%
	INSMED INCORPORATED					+69.73%
	Average					+75.34%
	Weighted average by Cap.					+26.34%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

1

Last Close Price

0.1669USD

Average target price

1.000USD

Spread / Average Target

+499.16%

High Price Target

1.000USD

Spread / Highest target

+499.16%

Low Price Target

1.000USD

Spread / Lowest Target

+499.16%

Analyst Consensus Detail

Analyst consensus - Northwest Biotherapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Northwest Biotherapeutics, Inc.

Stock Market
Stocks
NWBO Stock
Consensus Northwest Biotherapeutics, Inc.